CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
- Country
- 🇬🇧United Kingdom
- Ownership
- Subsidiary
- Established
- 1992-11-04
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.cuh.org.uk
Clinical Trials
340
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (259 trials with phase data)• Click on a phase to view related trials
PARTial BREast RECONstruction With Chest Wall Perforator Flap
- Conditions
- Breast Cancer Early Stage Breast Cancer (Stage 1-3)Breast CarcinomaBreast NeoplasmsBreast SurgeryBreast Reconstruction Surgery
- First Posted Date
- 2024-12-11
- Last Posted Date
- 2024-12-11
- Target Recruit Count
- 1001
- Registration Number
- NCT06728527
- Locations
- 🇬🇧
Cambridge University Hospitals NHS Trust, Cambridge, Cambridgeshire, United Kingdom
Utilising AI Analysis of Sounds To prEdict heaRt failurE decOmpensation
- Conditions
- Heart Failure
- First Posted Date
- 2024-08-15
- Last Posted Date
- 2024-08-15
- Target Recruit Count
- 250
- Registration Number
- NCT06555757
PDE3B in Metabolic Regulation
- Conditions
- Cardiometabolic SyndromeCardiovascular DiseasesType 2 Diabetes
- First Posted Date
- 2024-08-01
- Last Posted Date
- 2024-08-01
- Target Recruit Count
- 40
- Registration Number
- NCT06533007
Low-Dose IL-2 For The Reduction Of Vascular Inflammation In ACS -Clinical Outcomes & Follow-up Study
- Conditions
- Acute Coronary Syndromes
- Interventions
- Drug: Dextrose 5% in water
- First Posted Date
- 2024-05-24
- Last Posted Date
- 2024-06-10
- Target Recruit Count
- 60
- Registration Number
- NCT06427694
- Locations
- 🇬🇧
Addenbrooke's Hospital, Cambridge, Cambridgeshire, United Kingdom
Validation of AI Models to Measure Physical Activity After a Stroke
- Conditions
- Stroke
- First Posted Date
- 2023-09-11
- Last Posted Date
- 2023-09-11
- Target Recruit Count
- 34
- Registration Number
- NCT06030323
- Locations
- 🇬🇧
Cambridge University Hospital NHS Foundation Trust, Cambridge, Cambridgeshire, United Kingdom
- Prev
- 1
- 2
- 3
- 4
- 5
- 31
- Next
News
NIHR Pilots 'Just in Time' Clinical Trial Initiative for Pancreatic Cancer Using Pembrolizumab-Olaparib Combination
The National Institute for Health and Care Research is piloting a 'Just in Time' scheme that could reduce clinical trial setup time from months to days, potentially improving patient access to trials closer to home.
Capsule Sponge Test Shows Promise as Alternative to Endoscopy for Barrett's Esophagus Monitoring
A new "pill-on-a-string" capsule sponge test successfully identified 54% of Barrett's esophagus patients as low-risk, potentially eliminating the need for invasive endoscopy surveillance in these cases.
First European Patient Receives Breakthrough Treatment for Ultra-Rare APDS Immune Disorder
Mary Catchpole, 19, becomes the first European patient to receive leniolisib (Joenja), a newly approved targeted treatment for activated PI3-kinase delta syndrome (APDS), a rare inherited immune disorder.
NHS Becomes First European Health System to Trial Revolutionary Histotripsy Cancer Treatment
The NHS will be the first health system in Europe to trial histotripsy, a non-invasive ultrasound technology that destroys liver tumors using sound waves to create "bubble clouds" that pulverize cancer cells.
Olaparib Before Surgery Shows 100% Survival Rate in BRCA-Mutated Breast Cancer Patients
A groundbreaking clinical trial led by Addenbrooke's Hospital demonstrates 100% three-year survival rate for patients with BRCA-mutated breast cancer when treated with olaparib plus chemotherapy before surgery.
Archer Platform Launches at Cambridge University Hospitals to Revolutionize Clinical Trial Data Management
IgniteData, AstraZeneca, and Cambridge University Hospitals have launched the Archer platform in a Phase 3 clinical trial, automating data transfer between electronic health records and clinical trial databases.
Morning Asthma Testing Yields More Reliable Results, Study Reveals Significant Seasonal Variations
Research analyzing 1,600 patient records shows asthma spirometry tests are 8% more reliable for each hour closer to 8:30 AM, highlighting the impact of circadian rhythms on diagnostic accuracy.
UK-First Study on Pediatric Brain Trauma Features Remarkable Recovery of 12-Year-Old Quad Bike Accident Survivor
A groundbreaking UK study involving 135 children across ten pediatric intensive care units examines pressure reactivity index monitoring in traumatic brain injuries, aiming to improve treatment outcomes.
Key Advances in Inflammatory Bowel Disease: New Therapies, Treatment Strategies, and Long-Term Data
Early, intensive 'top-down' therapy with TNF blockers plus immunomodulators shows superior outcomes compared to the traditional 'step-up' approach for newly diagnosed Crohn's disease.
UK Boy Enrolls in Global Trial for Novel Low-Grade Glioma Drug
A six-year-old boy from Peterborough is the first UK participant in a global clinical trial for a novel drug targeting low-grade gliomas.